Neuronetics
STIM
102 hedge funds and large institutions have $63.2M invested in Neuronetics in 2025 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 4 closing their positions.
1,450% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 4
418% more capital invested
Capital invested by funds: $12.2M → $63.2M (+$51M)
127% more funds holding
Funds holding: 45 → 102 (+57)
51% more call options, than puts
Call options by funds: $493K | Put options by funds: $326K
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
21.28% more ownership
Funds ownership: 23.54% → 44.82% (+21%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.02M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.74M |
| 3 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$3.36M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.78M |
| 5 |
Millennium Management
New York
|
+$2.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
-$1.83M |
| 2 |
FCM
FourWorld Capital Management
New York
|
-$1.31M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.06M |
| 4 |
Renaissance Technologies
New York
|
-$383K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$325K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WIA
101
Wealthedge Investment Advisors
New York
| – | -$56.7K | -35,199 | Closed |
|
|
XT
102
XTX Topco
George Town,
Cayman Islands
| – | -$49.4K | -30,689 | Closed |
|
|
QOP
103
Quinn Opportunity Partners
Charlottesville,
Virginia
| – | -$32.2K | -20,000 | Closed |
|
104
Lazard Asset Management
New York
| – | -$2.32K | -636 | -85% |
|
STIM Hedge Fund Activity: Q1 2025 in Review
102 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q1 2025, worth a combined $63.2M — up 418% from $12.2M a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new STIM positions and 4 closed out — a net gain of 58 holders — while 15 added to existing stakes and 12 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $4.02M. The largest seller was Masters Capital Management, cutting an estimated $1.83M.
- 102 institutional investors held Neuronetics (STIM) as of Q1 2025, up from 45 in Q4 2024.
- Funds reported $63.2M of Neuronetics stock for Q1 2025, up 418% quarter-over-quarter.
- 62 funds opened new Neuronetics positions in Q1 2025 and 4 closed out, a net change of +58 holders.
- The largest Neuronetics buyer in Q1 2025 was Ikarian Capital, an estimated $4.02M added.
- The largest Neuronetics seller in Q1 2025 was Masters Capital Management, an estimated $1.83M sold.
Based on aggregated 13F filings for Q1 2025.